2013
DOI: 10.7314/apjcp.2013.14.11.6673
|View full text |Cite
|
Sign up to set email alerts
|

Calpain-10 SNP43 and SNP19 Polymorphisms and Colorectal Cancer: a Matched Case-control Study

Abstract: Objective: Insulin resistance (IR) is an established risk factor for colorectal cancer (CRC). Given that CRC and IR physiologically overlap and the calpain-10 gene (CAPN10) is a candidate for IR, we explored the association between CAPN10 and CRC risk. Methods: Blood samples of 400 case-control pairs were genotyped, and the lifestyle and dietary habits of these pairs were recorded and collected. Unconditional logistic regression (LR) was used to assess the effects of CAPN10 SNP43 and SNP19, and environmental f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 51 publications
(53 reference statements)
0
3
0
Order By: Relevance
“…Some scientists identified that the calpain-10 (CAPN10) gene is the first candidate type 2 diabetes mellitus (T2DM) gene, which is associated with decreased glucose tolerance and insulin resistance (IR) phenotypes by genome-wide linkage and positional cloning. Previous studies suggested that CAPN10 is important for IR, which is relevant to CRC risk (23). Consequently, results from foregoing study also support our hypothesis that, for patients whose expression level of CAPN10 is low and clinicopathological characteristics are comparable, survival chances are higher.…”
Section: Discussionmentioning
confidence: 99%
“…Some scientists identified that the calpain-10 (CAPN10) gene is the first candidate type 2 diabetes mellitus (T2DM) gene, which is associated with decreased glucose tolerance and insulin resistance (IR) phenotypes by genome-wide linkage and positional cloning. Previous studies suggested that CAPN10 is important for IR, which is relevant to CRC risk (23). Consequently, results from foregoing study also support our hypothesis that, for patients whose expression level of CAPN10 is low and clinicopathological characteristics are comparable, survival chances are higher.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the mutation of ABL1 was also elevated in CRC patients. Based on the results from previous studies, the mutation rate of the ABL1 gene is relatively higher in men than in women patients with CRC worldwide (3,23). In a previous study, the ABL1 gene was found to be mutated in 0.9% of patients with CRC at Sir Ganga Ram Hospital, Delhi, India (5).…”
Section: Discussionmentioning
confidence: 99%
“…Glucose metabolism dysregulation is a feature of malignant cancer that results in decreased insulin sensitivity and IR. IR is a high risk factor for multiple cancers (Hu et al, 2013). The prevention of IR represents one of the most important strategies to reduce the risk of postoperative recurrence.…”
Section: Discussionmentioning
confidence: 99%